Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K
Cancer02:18

Cancer

56.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
56.3K
Metastasis02:30

Metastasis

7.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

855
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
855
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

6.5K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NMR-Based Metabolic Profiling of Biobank Derived Blood Samples for the Identification of Liver Disease Biomarkers.

Biomolecules & therapeutics·2026
Same author

Pharmacomultiomics suggests new off-targets for targeted anti-cancer agents.

Journal of pharmaceutical analysis·2026
Same author

<i>MetaHarmonizer</i> : robust biomedical metadata harmonization and a contamination control for inflated LLM performance on public benchmarks.

bioRxiv : the preprint server for biology·2026
Same author

Large-scale manual curation and harmonization of metadata from metagenomic and cancer genomic repositories: challenges and solutions.

Database : the journal of biological databases and curation·2026
Same author

Machine learning approach for adult age estimation using dental characteristics on panoramic radiographs.

Scientific reports·2026
Same author

Altered acetate metabolism and signaling in IgA nephropathy: an integrated gut microbiome and glomerular spatial transcriptome analysis.

Frontiers in immunology·2026
Same journal

Tumor organoid platform design for drug response modeling: culture architecture, microenvironmental complexity, and AI-assisted readouts.

Archives of pharmacal research·2026
Same journal

Acetylation-dependent regulation of FOX-Ku interaction by GCN5-SIRT1 axis controls non-homologous end-joining DNA repair.

Archives of pharmacal research·2026
Same journal

Exercise-induced myokines in metabolic regulation: mechanisms, mimetics, and translational potential.

Archives of pharmacal research·2026
Same journal

eHsp90α enhances breast cancer cell invasion by activating the LRP1-EGFR/AKT-twist/snail signaling axis in cancer-associated fibroblasts.

Archives of pharmacal research·2026
Same journal

Liver organoids for chemical risk assessment: biological fidelity, standardization, and context-of-use frameworks.

Archives of pharmacal research·2026
Same journal

M2 microglial exosomal miR-1949 ameliorates sepsis-associated encephalopathy through DKK1/Wnt/β-catenin-mediated microglial repolarization.

Archives of pharmacal research·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry
11:39

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

Published on: June 9, 2019

9.9K

Cancer metabolomics in basic science perspective.

Hyuknam Kwon1, Sehyun Oh, Xing Jin

  • 1College of Pharmacy, Natural Product Research Institute, Seoul National University, Sillim-dong, Gwanak-gu, Seoul, 151-742, Korea.

Archives of Pharmacal Research
|January 30, 2015
PubMed
Summary
This summary is machine-generated.

Metabolomics offers a metabolite-oriented view of cancer, revealing how metabolic changes and specific metabolites drive tumorigenesis. This approach provides insights into epigenetic factors and cancer phenotypes.

More Related Videos

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

17.1K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.4K

Related Experiment Videos

Last Updated: Apr 18, 2026

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry
11:39

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

Published on: June 9, 2019

9.9K
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

17.1K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.4K

Area of Science:

  • Oncology
  • Metabolomics
  • Epigenetics

Background:

  • Cancer metabolism is complex, involving intricate signaling and metabolic pathways.
  • Current understanding often focuses on proteins, overlooking the direct role of metabolites.
  • Metabolic profiles can reflect environmental and epigenetic influences in cancer.

Purpose of the Study:

  • To review the metabolite-oriented perspective on cancer metabolism.
  • To highlight metabolomics' contribution to understanding cancer's basic mechanisms.
  • To explore how specific metabolites and pathways drive tumorigenesis and cancer phenotypes.

Main Methods:

  • Review of existing metabolomics research in cancer.
  • Analysis of specific metabolites and enzymatic pathways linked to cancer.
  • Examination of metabolite-mediated regulation of signaling and metabolic enzymes.

Main Results:

  • Metabolomics provides crucial insights into cancer's metabolic alterations.
  • Specific metabolites and pathways are directly implicated in tumorigenesis.
  • Metabolites actively regulate signaling proteins and enzymes, influencing cancer phenotypes.

Conclusions:

  • A metabolite-oriented view is essential for understanding cancer metabolism.
  • Metabolomics is a powerful tool for uncovering epigenetic relevance in cancer.
  • Future research should leverage metabolomics to address challenges in cancer research.